Pfizer is a pharmaceuticals and biotechnology company that supports wellness and prevention
Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 13, 1978 | IPO | — | — | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 21, 2022
ORIC Pharmaceuticals
|
Post-IPO Equity | $25M | Biotechnology | Yes |
Dec 1, 2022
Carrick Therapeutics
|
Series C | $60M | Biotechnology | Yes |
Sep 20, 2022
CytoReason
|
Corporate Round | $20M | Biopharma | Yes |
Jun 20, 2022
Valneva
|
Post-IPO Equity | €90.50M | Biotechnology | Yes |
Jun 14, 2022
Dren Bio
|
Series B | $65M | Biotechnology | — |
Pfizer has had 18 exits. Pfizer most notable exits include LianBio , Sema4
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Nov 1, 2021 | LianBio | IPO | Biopharma | Detail |
Jul 23, 2021 | Sema4 | IPO | Artificial Intelligence | Detail |
May 6, 2021 | Valneva | IPO | Biotechnology | Detail |
Apr 28, 2021 | Amplyx Pharmaceuticals | M&A | Biotechnology | Detail |
Oct 28, 2020 | Cerevel Therapeutics | IPO | Biotechnology | Detail |
Pfizer has acquired 38 organizations. Their most recent acquisition was Warner-Lambert on Feb 7, 2000. They acquired Warner-Lambert for $90B.
Date
Company Name
|
Industry | Acquisition Type | Price | |
---|---|---|---|---|
Feb 7, 2000
Warner-Lambert
|
Biotechnology | acquisition | $ 90B | Detail |
Jul 15, 2002
Pharmacia
|
Biotechnology | — | — | Detail |
Dec 21, 2003
Esperion
|
Biotechnology | acquisition | $ 1.30B | Detail |
Jan 21, 2005
Angiosyn
|
Biotechnology | acquisition | — | Detail |
Feb 24, 2005
Idun Pharmaceuticals
|
Biopharma | acquisition | — | Detail |